Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Bhupinder Natt
Associate Professor, Medicine - (Clinical Scholar Track)
Medicine
Overview
Research
More
Collaboration
(25)
Sairam Parthasarathy
Mutual work: 2 Publications
Collaboration Details
Kenneth Knox
Mutual work: 9 Publications
Collaboration Details
Jarrod Mosier
Mutual work: 35 Publications
Collaboration Details
Karen Lutrick
Mutual work: 1 Publication
Collaboration Details
Christian Bime
Mutual work: 20 Publications
Collaboration Details
Page 1 of 5
Previous page
Next page
Grants
(3)
An Open-label Extension Trial of the Long-term Safety and Efficacy of BI 1015550 Taken Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF)
Active
·
2024
·
$0 / $395K
·
External
Co-Investigator (COI)
pulmonary fibrosis,
long-term safety,
efficacy,
idiopathic pulmonary fibrosis
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Bi 1015550 Over at Least 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Diseases (Pf-ilds)
Active
·
2023
·
$0 / $272K
·
External
Co-Investigator (COI)
clinical trials,
interstitial lung diseases,
drug efficacy,
patient safety,
progressive fibrosing
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)
Active
·
2020
·
$433.9K
·
External
Principal Investigator (PI)
pulmonary fibrosis,
clinical trial,
efficacy,
safety,
treatment
Publications
(88)
Recent
Interstitial Lung Disease Mortality Disparities Along the US-Mexico Border, 1999-2020
2024
lung disease,
mortality,
disparities,
us-mexico border,
epidemiology
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension
2023
sepsis,
fluid management,
hypotension,
early intervention,
critical care
Outcomes of Venovenous Extracorporeal Membrane Oxygenation in Viral Acute Respiratory Distress Syndrome
2022
extracorporeal membrane oxygenation,
viral acute respiratory distress syndrome,
outcomes,
respiratory support,
viral infections
Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry
2022
quality of life,
disease progression,
interstitial lung disease,
patient registry,
pulmonary fibrosis
Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease
2022
quality of life,
disease progression,
interstitial lung disease,
patients
Prophylaxis in Lung Transplant Recipients
2022
prophylaxis,
lung transplant,
recipients,
immunosuppression,
infection control
IS CRITICAL CARE MYOPATHY A CONTRAINDICATION FOR SUCCINYLCHOLINE?
2021
critical care myopathy,
succinylcholine,
contraindication,
critical care,
myopathy
Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States: The Severe ARDS: Generating Evidence Study
2021
critical care,
ards,
healthcare practices,
clinical management,
epidemiology
Corrigendum: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused Front. Med. 2020) 7, 539) 10.3389/fmed.2020.00539)
2021
covid-19,
lung disease,
antifibrotics,
medicine,
research
Airway Management in the Critically Ill Patient
2021
airway management,
critical care,
patient safety,
intensive care,
anesthesia
